Zobrazeno 1 - 10
of 37
pro vyhledávání: '"James W. Jacobson"'
Publikováno v:
Limnology and Oceanography: Methods. 8:269-284
Harmful algal blooms (HABs) are a serious public health risk in coastal waters. As the intensity and frequency of HABs continue to rise, new methods of detection are needed for reliable identification. Herein, we developed a high-throughput, multiple
Autor:
Jesse V. Jokerst, James W. Jacobson, John T. McDevitt, Pierre N. Floriano, Bryon D. Bhagwandin, Nicolaos Christodoulides
Publikováno v:
Analytical Chemistry. 82:1571-1579
There have been many recent advances in the nano-bio-chip (NBC) analysis methodology with implications for a number of high-morbidity diseases including HIV, cancer, and heart disease. In their Feature article, Jesse V. Jokerst of The University of T
Autor:
Matthew Meyerson, Kevin K. Dobbin, Daniel Strumpf, Kerby Shedden, Samir M. Hanash, Janos Szoke, William L. Gerald, Frances A. Shepherd, Barbara A. Weir, Agnes Viale, Keyue Ding, David G. Beer, Mark G. Kris, Barbara A. Conley, Roeland Verhaak, Todd R. Golub, Maureen F. Zakowski, Anupama Sharma, Timothy J. Yeatman, Michael Gruidl, Tracy Lively, James W. Jacobson, Jeremy M. G. Taylor, David E. Misek, Steven A. Enkemann, Katsuhiko Naoki, Thomas J. Giordano, Igor Jurisica, Venkatraman E. Seshan, Noriko Motoi, Rork Kuick, Valerie W. Rusch, Steven A. Eschrich, Christine Ladd-Acosta, Lesley Seymour, William D. Travis, Chang-Qi Zhu, Nathan A. Pennell, Andrew C. Chang, Ming-Sound Tsao
Publikováno v:
Nature Medicine. 14:822-827
Although prognostic gene expression signatures for survival in early-stage lung cancer have been proposed, for clinical application, it is critical to establish their performance across different subject populations and in different laboratories. Her
Autor:
Jose R. C. M. van Beckhoven, Jan M. van der Wolf, James W. Jacobson, Jeroen Peters, Gé W. van den Bovenkamp, Jan H. W. Bergervoet
Publikováno v:
Journal of Virological Methods, 149(1), 63-68
Journal of Virological Methods 149 (2008) 1
Journal of Virological Methods 149 (2008) 1
To monitor seed potatoes for potato virus X, Y and PLRV, a multiplex microsphere immunoassay (MIA) was developed based on the Luminex xMAP technology, as an alternative to ELISA. The xMAP technology allowed detection of a number of antigens simultane
Autor:
James W. Jacobson, Sherry A. Dunbar
Publikováno v:
Clinical Microbiology Newsletter. 29:79-86
Multiplexed testing — simultaneous analysis of multiple analytes from the same sample — is rapidly becoming a standard in research and clinical laboratories. Drivers for multiplexing include cost savings, labor efficiencies, sample conservation,
Publikováno v:
Cytometry Part A. :384-390
Introduction: Typically, bead-based assays (“bead arrays”) use the mean or median value of a population of measurements to judge ligand binding or other activity, which results in a change in fluorescence intensity. Individual bead measurements a
Publikováno v:
American Journal of PharmacoGenomics. 5:357-364
A new diagnostic tool must pass three major tests before it is adopted for routine clinical use. First, the tool must be robust and reproducible; second, the clinical value of the tool must be proven, i.e. the tool should reliably trigger a clinical
Autor:
James V. Tricoli, James W. Jacobson
Publikováno v:
Cancer Research. 67:4553-4555
The Cancer Diagnosis Program of the National Cancer Institute sponsored a workshop entitled “MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis” in Rockville, Maryland on November 28 and 29, 2006. The purpose of this workshop was
Publikováno v:
Journal of Mammalogy. 79:594-603
Determining mating strategies and social behavior of natural populations of mammals is equivocal when individuals can not be observed directly. DNA fingerprinting holds promise to elucidate relationships among individuals indirectly; however, few emp
Autor:
James W. Jacobson, H. James Voeller, Ralph W deVere White, Xu-Bao Shi, Paul H. Gumerlock, Sung Gil Chi, Edward P. Gelmann
Publikováno v:
JNCI Journal of the National Cancer Institute. 89:66-71
Background: The reported frequency of mutation of the p53 tumor suppressor gene (also known as TP53) in human carcinomas of the prostate has varied widely, ranging from 3% to 42%. This variability may be a consequence of tumor heterogeneity and/or th